Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04274907
Title A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AbbVie
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab + Venetoclax

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST